Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)

Recruiting

Observational StudyStudy of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)

Sponsor:

Corcept Therapeutics

Code:

NCT06829537

Conditions

Resistant Hypertension

Hypercortisolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-30. This information was provided to ClinicalTrials.gov by Corcept Therapeutics on 2025-08-27.